Previous Page  5 / 32 Next Page
Information
Show Menu
Previous Page 5 / 32 Next Page
Page Background

Page 51

Notes:

https://www.pulsus.com/dentistry-case-report.html

Dentistry: Case Report

Euro Dentistry 2017

September 20-21, 2017

25

th

Euro Dentistry Congress

September 20-21, 2017 Dublin, Ireland

Patrick Ottensmeyer, Dentistry: Case Report

HOXA11 pre-selected human mesenchymal stem cells from different body parts for enhanced

osteoblastogenesis

Patrick Ottensmeyer

Bonn-Rhine-Sieg University of Applied Sciences, Germany

I

n dental surgery new bone reconstructive therapies are of great interest. Bone grafts are usually provided from autologous, allogenic,

or xenogenic sources that are either not available in sufficient amounts or carry the risk of immunogenic reactions. A promising

new approach is the use of human mesenchymal stem cells from the patient in combination with scaffolds. We showed recently,

that stem cells from the head region are pre-committed towards hard tissues and address the question, if there are cells from other

body parts, that are easier to obtain and similar pre-committed.

HOX

genes are a highly conserved family of 39 transcription factors

defining the limp development along the cranio-caudal axis and thus are potential biomarkers for the osteogenic potential of stem

cells isolated from different body parts. Collagen scaffolds were tested for their successful support of attachment and growth of freshly

isolated primary cells. Mesenchymal stem cells from neck, thigh, and belly were isolated from liposuction material and differentiated

towards the osteogenic lineage. The

HOX

gene pattern was investigated before and after differentiation via gene array analysis and

RT-PCR. The osteogenic differentiation was confirmed via Alizarin Red S staining. Interestingly one member of this gene family,

namely

HOX

A11, is up-regulated during in vitro osteogenesis. In addition, mesenchymal stem cells from the belly region showed

the highest basal expression of

HOX

A11 and the strongest staining with Alizarin Red S. One hurdle for the use of mesenchymal stem

cells in regenerative dentistry is their low differentiation efficiency. Since liposuction material can be obtained from various body

regions defining the most pre-committed stem cells for osteogenesis might improve their future use in bone regeneration by reducing

unwanted side effects. For this

HOX

A11 can be a suitable marker gene. Collagen scaffolds with their good biocompatibility might

serve as an intermediate to bridge the gap until the defect jawbone is reconstructed. The combination of

HOX

A11 preselected stem

cells and collagen scaffolds might therefore be a promising alternative to current strategies in regenerative dentistry.